178601-89-3

Basic information

• Product Name: 7S-Cefdinir
• Synonyms: 7S-Cefdinir;(6R,7S)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
• CAS NO: 178601-89-3
• Molecular Formula: C₁₄H₁₃N₅O₅S₂
• Molecular Weight: 395.41352
• Product Categories: Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds
• Mol File: 178601-89-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7S-Cefdinir(CAS DataBase Reference)
• NIST Chemistry Reference: 7S-Cefdinir(178601-89-3)
• EPA Substance Registry System: 7S-Cefdinir(178601-89-3)

Safety Data

• Hazardous Substances Data: 178601-89-3(Hazardous Substances Data)

Usage

Description

7S-Cefdinir is an isomer of Cefdinir (C242670), a Cephalosporin antibiotic that is structurally similar to Cefixime. It is a semi-synthetic antibiotic derived from the Cephalosporium acremonium fungus. 7S-Cefdinir possesses bactericidal properties and is effective against a range of Gram-negative and Gram-positive bacteria, making it a valuable pharmaceutical agent for treating various infections.

Uses

Used in Pharmaceutical Industry:
7S-Cefdinir is used as an antibiotic agent for treating infections caused by several Gram-negative and Gram-positive bacteria. Its bactericidal action is attributed to its ability to inhibit bacterial cell wall synthesis, leading to cell lysis and death. This makes it a suitable treatment option for a variety of bacterial infections, including respiratory, skin, and urinary tract infections.

Relevant articles and documents

Novel crystalline form of cefdinir

The present invention relates to novel crystalline form of Cefdinir, 7β-[(Z)-2-(2-amino-4-thiazolyl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid, herein referred as cefdinir crystal B, processes for preparing cefdinir crystal B, and the incorporation of cefdinir crystal B in pharmaceutical compositions.